NIH-funded research R01 grant

Understanding and treating exercise intolerance after COVID-19

Official title: Pathogenic Mechanism and Therapeutic Approaches for Exercise Intolerance in Post-Acute Sequelae of COVID-19

Funded at University of Pittsburgh at Pittsburgh · NIH-11019369 · Data updated 2026-11-12

This study is looking into why some people have trouble exercising after recovering from COVID-19, and it aims to find out how certain factors in the body might be affecting their ability to be active, which could help improve treatments for those facing these challenges.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startApril 1, 2025
Project endJanuary 31, 2029
Funding year2025
Award (this year)$633,045
NIH project number1R01HL176493-01
Project IDNIH-11019369 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults aged 21 and older who are experiencing exercise intolerance following a COVID-19 infection.

Less likely to help

Patients who have not experienced exercise intolerance or those who have not had a confirmed COVID-19 infection may not benefit from this research.

What this research studies

This research investigates the causes of exercise intolerance in patients who have experienced post-acute sequelae of COVID-19 (PASC). The team will utilize advanced cardiopulmonary exercise testing to identify molecular and physiological factors that contribute to this condition. By exploring the role of angiotensin-converting enzyme 2 (ACE2) and its relationship with exercise capacity, the research aims to uncover potential biomarkers and therapeutic targets. The findings could lead to improved treatment strategies for those affected by exercise limitations following COVID-19.

Why it matters

Potential benefit: If successful, this research could lead to targeted therapies that significantly improve exercise capacity and quality of life for patients suffering from PASC.

How similar studies have gone: Other research has shown promising results in understanding the long-term effects of COVID-19, but this specific investigation into exercise intolerance is relatively novel.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Zhang, Lianghui — University of Pittsburgh at Pittsburgh
  • Study coordinator: Zhang, Lianghui

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.